Trondheim-based biotech company Vitroscope has raised $7 million in a financing package comprising a $5 million seed round co-led by Cerberus Ventures and YZR Capital, alongside $2 million in non-dilutive funding from the Research Council of Norway. Arcas Ventures, Golden Egg Check, Devico Invest and angel investors Carles Reina, Fàtima Godall and Oskari Pétas also participated in the seed round. Vitroscope develops automated perfusion platforms that maintain living tissue under controlled flow conditions, enabling researchers to study immune activity, disease mechanisms and treatment responses over time. The funding will support the commercial rollout of its vitro.alive benchtop platform and validation of vitro.scale, a...
Read the full article at the source.
Comments (0)
No comments yet. Be the first to comment!